Coming out of the Great Recession, a handful of companies have powered the index to record highs.
Carl Icahn's reportedly focusing his brand of investor activism on Bristol-Myers Squibb, but it's anyone's guess if he'll be able to convince the company to sell. Also, Celgene delivers a phase 3 win with blockbuster implications.
You can learn a lot about Berkshire Hathaway by examining the trend in its annual performance since 1965.
The refining giant's stock has stagnated lately, which might make now a great time to buy.
The Omaha conglomerate reported that net income soared because of investment gains, but operating profit from its diversified business units declined in the fourth quarter.
Buffett sold nearly all of his remaining stake in the retail giant. It's a teachable moment for investors.
A few famous investors have amassed big positions in Apple, Sears Holdings, and Antero Resources, but should retail investors follow suit?
The Oracle of Omaha and his team made some big moves in 2016.
The Oracle of Omaha called out the bank in his latest annual letter.
The human capital management software company landed a baker's dozen Fortune 500 accounts en route to a record fourth quarter.